Latest filing published 04 Dec 2019 for Oasmia Pharmaceutical AB, €7,150.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Carl Ewert Af Winklerfelt: trading record in brief
Michael Carl Ewert Af Winklerfelt is a declared insider of Oasmia Pharmaceutical AB, with filings sourced from Finansinspektionen. We count 4 filings; the first trade dates from 26 November 2019 and the latest from 4 December 2019.
On the market, this insider has only ever bought: 3 purchases, €7,081 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €2,128.
The newest entry dates from 4 December 2019: a transaction of €7,150, in Oasmia Pharmaceutical AB. The most recent open-market purchase was published on 29 November 2019, 2,536 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Michael Carl Ewert Af Winklerfelt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,760 shares@ SEK 2.0059.1% of flowBTA (betald tecknad aktie)ISIN SE0010101188FI:csv-78b5d8434e0065d7f3f7
- 5,367 shares@ SEK 1.747.3% of flowTeckningsrättISIN SE0013460540FI:csv-576b482d8f3ce1d9db2fCanonical exit: 27 Feb 2020 (T+90)
- 24,583 shares@ SEK 1.7433.6% of flowTeckningsrättISIN SE0013460540FI:csv-7071203aa580d56fee94Canonical exit: 27 Feb 2020 (T+90)
- 17,250 shares@ SEK 1.31100.0% of flowTeckningsrättISIN SE0013460540FI:csv-f386a579f903c8b284f4Canonical exit: 24 Feb 2020 (T+90)
4 of 4 declarations